Cargando…
Oral mucosal immunotherapy for allergic rhinitis: A pilot study
BACKGROUND: The sublingual mucosa has been used for many years to apply allergenic extracts for the purpose of specific immunotherapy (IT). Although sublingual IT (SLIT) is both safe and efficacious, the density of antigen-presenting cells is higher in other regions of the oral cavity and vestibule,...
Autores principales: | Reisacher, William R., Suurna, Maria V., Rochlin, Kate, Bremberg, Maria G., Tropper, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OceanSide Publications, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837130/ https://www.ncbi.nlm.nih.gov/pubmed/27103556 http://dx.doi.org/10.2500/ar.2016.7.0150 |
Ejemplares similares
-
Sublingual immunotherapy in allergic rhinitis
por: Han, Doo Hee, et al.
Publicado: (2011) -
Allergen immunotherapy and allergic rhinitis: false beliefs
por: Calderón, Moisés A, et al.
Publicado: (2013) -
Mechanisms of Allergen Immunotherapy in Allergic Rhinitis
por: Drazdauskaitė, Gabija, et al.
Publicado: (2020) -
Immunotherapy in the Treatment of Allergic Rhinitis in Children
por: Alamri, Ruba A, et al.
Publicado: (2022) -
Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis
por: Uller, Lena, et al.
Publicado: (2010)